Tradestie Institutional Equity Comparison Engine
ORKA vs MANE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ORKA Overall Edge
ORKA Captures Institutional Edge (3โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Oruka Therapeutics, Inc. Common Stock (ORKA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ORKA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MANE at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ORKA sits in BREAKOUT (19th %ile IV; Dealer Gamma Walls on Pro) against MANE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ORKA N/M vs MANE N/M Fwd P/E
Growth & Margin Winner
ORKA
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
ORKA
1Y +278.4% vs +239.2% ยท 52W Pos 83% vs 77%
Options & Structure Winner
ORKA
BREAKOUT (19th %ile IV) vs UNCLASSIFIED (N/A IV)
ORKA
NASDAQ
Oruka Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$99.83
-5.23% 1D
Market Cap
$7.1B
1M Return
+38.79%
1Y Return
+278.45%
Forward P/E
N/M
Unified AI Score
43.3 / 100
HOLD
Tech 24.0
Fund 40.0
Flow 69.0
Mom 50.0
MANE
US Equity
MANE
Institutional Equity
$128.03
-1.26% 1D
Market Cap
N/A
1M Return
+17.65%
1Y Return
+239.15%
Forward P/E
N/M
Unified AI Score
38.1 / 100
SELL
Tech 15.0
Fund 36.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ORKA +278.45%
MANE +239.15%
Spread: +36.62 pp (MANE Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ORKA TTM Op. Margin: 0.0%
MANE TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ORKA vs MANE. Trailing 12-month operating profitability (ORKA 0.0% vs MANE N/A) and valuation multiples (ORKA N/M vs MANE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ORKA | MANE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.1B | N/A | Larger Scale | ORKA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | ORKA |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | ORKA |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | ORKA |
| Return on Equity (ROE) Capital Efficiency | -18.1% | N/A | Higher ROE | ORKA |
| 52-Week Range Position Momentum | 83% ($25โ$116) | 77% ($32โ$157) | Stronger Trend | ORKA |
| Beta / 30D Volatility Risk Regime | 1.35ฮฒ ยท 68% Vol | 1.28ฮฒ ยท 80% Vol | Lower Realized Risk | ORKA |
| Unified Institutional Score Composite Signal | 43.3 / 100 (HOLD) | 38.1 / 100 (SELL) | Higher Composite | ORKA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ORKA vs MANE Buy Guide
ORKA
BREAKOUT
141d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
19th %ile
IV Regime
Compressed (<25th %ile)
MANE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ORKA nor MANE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.